Category Archive: NYSE:CVS

Walgreens Hints More Partnerships, Not Big Deals In The Future

Walgreens will escalate its partnership strategy, which the drugstore chain says effectively brings scale and market share gains across the U.S.

DOJ Clears CVS-Aetna Deal Once Medicare Drug Plans Are Unloaded

The U.S. Justice Department agreed to allow CVS Health’s acquisition of health insurance giant Aetna once Aetna’s Medicare Part D prescription drug plan business for individuals is divested.

As Open Enrollment Begins, Record Medicare Advantage Growth Expected

Seniors will see a 20% increase in the number of Medicare Advantage plan choices for 2019 when they begin open enrollment Oct. 15.

Despite New Rite Aid Governance, Shareholder Unrest Remains

Rite Aid’s board and CEO face an uncertain vote from shareholders at the company’s annual meeting Oct. 30.

Despite New Rite Aid Governance, Shareholder Unrest Remains

Rite Aid’s board and CEO face an uncertain vote from shareholders at the company’s annual meeting Oct. 30.

Can Pharmacists Revolutionize Primary Care in the United States?

There is a primary care shortage in America. Can pharmacists be the answer?

Rite Aid’s PBM Key To Any Revival

Rite Aid’s EnvisionRx PBM is targeting the booming business of aging baby boomers buying Medicare Part D drug plans.

Wellcare To Buy Aetna’s Medicare Drug Plans, Easing A CVS Antitrust Issue

Aetna said it will sell its Medicare drug plans to WellCare Health Plans as part of a divestiture to help the insurer win Justice Department approval of its sale to CVS Health.

Rite Aid Shakes Up Board, Strips CEO Of Chairmanship After Failed Merger

Rite Aid unveiled new governance, stripping CEO John Standley of the company’s chairmanship and adding new board members in the wake of a failed merger and mounting financial losses.

Pressure Mounts On Rite Aid To Find A Partner

Rite Aid faces intensifying pressure to find a strategic partner one month after its merger with Albertsons fell apart.

Older posts «

Explore the Archive